Skip to main content

HCC 20: Lung and Other Severe Cancers

HCC 20, Lung and Other Severe Cancers, is one of the 115 payment categories in the CMS-HCC V28 model. 233 ICD-10-CM codes map to it in the payment year 2027 mapping, and a documented diagnosis in the category adds a relative factor of 1.136 to the risk score of a community, non-dual, aged beneficiary (0.978 disabled, 0.672 institutional). It is overridden when a more severe category in its hierarchy is present (HCC 17, HCC 18, HCC 19) and it in turn overrides HCC 21, HCC 22, HCC 23. In its hierarchy, HCC 19 overrides it when both are coded, at a community aged factor of 1.798 (+0.662), and it overrides HCC 21 (0.671, -0.465), so a record coding both is paid this category's factor alone.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ICD-10-CM to HCC mapping: PY2027 initial ICD-10-CM mappings (dates of service 2026) (payment year 2027); CMS-HCC V28 model software: CMS-HCC V28 software V2826.115.T2 (PY2027 initial) (payment year 2027). Next CMS release: PY2028 advance notice (February 2027) and the PY2027 midyear final mapping (spring 2027).

Mapped ICD-10-CM codes
233
Factor, community non-dual aged
1.136
Factor, institutional
0.672
Hierarchy
Overridden by HCC 17, HCC 18, HCC 19
Disease group
Neoplasm

Relative factors by segment

Each segment is a separate regression; the factor is added to the beneficiary's demographic factors and other categories, then normalized and reduced by the coding intensity adjustment before it meets the plan's base rate. A factor of 1.000 equals the expected cost of an average beneficiary.

CMS-HCC V28 relative factors for HCC 20 by model segment
SegmentModel codeRelative factor
Community, non-dual, agedCNA_HCC201.136
Community, non-dual, disabledCND_HCC200.978
Community, full-benefit dual, agedCFA_HCC201.166
Community, full-benefit dual, disabledCFD_HCC201.173
Community, partial-benefit dual, agedCPA_HCC201.214
Community, partial-benefit dual, disabledCPD_HCC201.067
Long-term institutionalINS_HCC200.672

Hierarchy

Hierarchical condition categories pay only the most severe manifestation of a disease. When HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) or HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid) or HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers) is also documented for the same beneficiary, HCC 20 is dropped from the score. When HCC 20 is present it drops HCC 21 (Lymphoma and Other Cancers), HCC 22 (Bladder, Colorectal, and Other Cancers), HCC 23 (Prostate, Breast, and Other Cancers and Tumors), so documenting the less severe condition alongside it adds nothing to payment but still matters for the clinical record.

ICD-10-CM codes that map to HCC 20

233 codes map to this category in the PY2027 initial mapping, concentrated in the C84 (55), C83 (45), C34 (16), C72 (14), C93 (12), C71 (10) code families. CMS built that mapping from codes valid in FY2025 and FY2026, and descriptions are the CMS mapping descriptions. None of these codes was deleted in the October 1, 2026 update.

ICD-10-CM codes mapped to HCC 20 in the CMS PY2027 initial mapping
ICD-10-CMDescription
C15.3Malignant neoplasm of upper third of esophagus
C15.4Malignant neoplasm of middle third of esophagus
C15.5Malignant neoplasm of lower third of esophagus
C15.8Malignant neoplasm of overlapping sites of esophagus
C15.9Malignant neoplasm of esophagus, unspecified
C16.0Malignant neoplasm of cardia
C16.1Malignant neoplasm of fundus of stomach
C16.2Malignant neoplasm of body of stomach
C16.3Malignant neoplasm of pyloric antrum
C16.4Malignant neoplasm of pylorus
C16.5Malignant neoplasm of lesser curvature of stomach, unspecified
C16.6Malignant neoplasm of greater curvature of stomach, unspecified
C16.8Malignant neoplasm of overlapping sites of stomach
C16.9Malignant neoplasm of stomach, unspecified
C17.0Malignant neoplasm of duodenum
C17.1Malignant neoplasm of jejunum
C17.2Malignant neoplasm of ileum
C17.3Meckel's diverticulum, malignant
C17.8Malignant neoplasm of overlapping sites of small intestine
C17.9Malignant neoplasm of small intestine, unspecified
C22.0Liver cell carcinoma
C22.1Intrahepatic bile duct carcinoma
C22.2Hepatoblastoma
C22.3Angiosarcoma of liver
C22.4Other sarcomas of liver
C22.7Other specified carcinomas of liver
C22.8Malignant neoplasm of liver, primary, unspecified as to type
C22.9Malignant neoplasm of liver, not specified as primary or secondary
C23Malignant neoplasm of gallbladder
C24.0Malignant neoplasm of extrahepatic bile duct
C24.1Malignant neoplasm of ampulla of Vater
C24.8Malignant neoplasm of overlapping sites of biliary tract
C24.9Malignant neoplasm of biliary tract, unspecified
C25.0Malignant neoplasm of head of pancreas
C25.1Malignant neoplasm of body of pancreas
C25.2Malignant neoplasm of tail of pancreas
C25.3Malignant neoplasm of pancreatic duct
C25.4Malignant neoplasm of endocrine pancreas
C25.7Malignant neoplasm of other parts of pancreas
C25.8Malignant neoplasm of overlapping sites of pancreas
C25.9Malignant neoplasm of pancreas, unspecified
C33Malignant neoplasm of trachea
C34.00Malignant neoplasm of unspecified main bronchus
C34.01Malignant neoplasm of right main bronchus
C34.02Malignant neoplasm of left main bronchus
C34.10Malignant neoplasm of upper lobe, unspecified bronchus or lung
C34.11Malignant neoplasm of upper lobe, right bronchus or lung
C34.12Malignant neoplasm of upper lobe, left bronchus or lung
C34.2Malignant neoplasm of middle lobe, bronchus or lung
C34.30Malignant neoplasm of lower lobe, unspecified bronchus or lung
C34.31Malignant neoplasm of lower lobe, right bronchus or lung
C34.32Malignant neoplasm of lower lobe, left bronchus or lung
C34.80Malignant neoplasm of overlapping sites of unspecified bronchus and lung
C34.81Malignant neoplasm of overlapping sites of right bronchus and lung
C34.82Malignant neoplasm of overlapping sites of left bronchus and lung
C34.90Malignant neoplasm of unspecified part of unspecified bronchus or lung
C34.91Malignant neoplasm of unspecified part of right bronchus or lung
C34.92Malignant neoplasm of unspecified part of left bronchus or lung
C38.0Malignant neoplasm of heart
C38.4Malignant neoplasm of pleura
C48.0Malignant neoplasm of retroperitoneum
C48.1Malignant neoplasm of specified parts of peritoneum
C48.2Malignant neoplasm of peritoneum, unspecified
C48.8Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum
C70.0Malignant neoplasm of cerebral meninges
C70.1Malignant neoplasm of spinal meninges
C70.9Malignant neoplasm of meninges, unspecified
C71.0Malignant neoplasm of cerebrum, except lobes and ventricles
C71.1Malignant neoplasm of frontal lobe
C71.2Malignant neoplasm of temporal lobe
C71.3Malignant neoplasm of parietal lobe
C71.4Malignant neoplasm of occipital lobe
C71.5Malignant neoplasm of cerebral ventricle
C71.6Malignant neoplasm of cerebellum
C71.7Malignant neoplasm of brain stem
C71.8Malignant neoplasm of overlapping sites of brain
C71.9Malignant neoplasm of brain, unspecified
C72.0Malignant neoplasm of spinal cord
C72.1Malignant neoplasm of cauda equina
C72.20Malignant neoplasm of unspecified olfactory nerve
C72.21Malignant neoplasm of right olfactory nerve
C72.22Malignant neoplasm of left olfactory nerve
C72.30Malignant neoplasm of unspecified optic nerve
C72.31Malignant neoplasm of right optic nerve
C72.32Malignant neoplasm of left optic nerve
C72.40Malignant neoplasm of unspecified acoustic nerve
C72.41Malignant neoplasm of right acoustic nerve
C72.42Malignant neoplasm of left acoustic nerve
C72.50Malignant neoplasm of unspecified cranial nerve
C72.59Malignant neoplasm of other cranial nerves
C72.9Malignant neoplasm of central nervous system, unspecified
C75.1Malignant neoplasm of pituitary gland
C75.2Malignant neoplasm of craniopharyngeal duct
C75.3Malignant neoplasm of pineal gland
C77.3Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes
C83.10Mantle cell lymphoma, unspecified site
C83.11Mantle cell lymphoma, lymph nodes of head, face, and neck
C83.12Mantle cell lymphoma, intrathoracic lymph nodes
C83.13Mantle cell lymphoma, intra-abdominal lymph nodes
C83.14Mantle cell lymphoma, lymph nodes of axilla and upper limb
C83.15Mantle cell lymphoma, lymph nodes of inguinal region and lower limb
C83.16Mantle cell lymphoma, intrapelvic lymph nodes
C83.17Mantle cell lymphoma, spleen
C83.18Mantle cell lymphoma, lymph nodes of multiple sites
C83.19Mantle cell lymphoma, extranodal and solid organ sites
C83.1AMantle cell lymphoma, in remission
C83.30Diffuse large B-cell lymphoma, unspecified site
C83.31Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck
C83.32Diffuse large B-cell lymphoma, intrathoracic lymph nodes
C83.33Diffuse large B-cell lymphoma, intra-abdominal lymph nodes
C83.34Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb
C83.35Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb
C83.36Diffuse large B-cell lymphoma, intrapelvic lymph nodes
C83.37Diffuse large B-cell lymphoma, spleen
C83.38Diffuse large B-cell lymphoma, lymph nodes of multiple sites
C83.390Primary central nervous system lymphoma
C83.398Diffuse large B-cell lymphoma of other extranodal and solid organ sites
C83.3ADiffuse large B-cell lymphoma, in remission
C83.50Lymphoblastic (diffuse) lymphoma, unspecified site
C83.51Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck
C83.52Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes
C83.53Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes
C83.54Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb
C83.55Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb
C83.56Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes
C83.57Lymphoblastic (diffuse) lymphoma, spleen
C83.58Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites
C83.59Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites
C83.5ALymphoblastic (diffuse) lymphoma, in remission
C83.70Burkitt lymphoma, unspecified site
C83.71Burkitt lymphoma, lymph nodes of head, face, and neck
C83.72Burkitt lymphoma, intrathoracic lymph nodes
C83.73Burkitt lymphoma, intra-abdominal lymph nodes
C83.74Burkitt lymphoma, lymph nodes of axilla and upper limb
C83.75Burkitt lymphoma, lymph nodes of inguinal region and lower limb
C83.76Burkitt lymphoma, intrapelvic lymph nodes
C83.77Burkitt lymphoma, spleen
C83.78Burkitt lymphoma, lymph nodes of multiple sites
C83.79Burkitt lymphoma, extranodal and solid organ sites
C83.7ABurkitt lymphoma, in remission
C84.00Mycosis fungoides, unspecified site
C84.01Mycosis fungoides, lymph nodes of head, face, and neck
C84.02Mycosis fungoides, intrathoracic lymph nodes
C84.03Mycosis fungoides, intra-abdominal lymph nodes
C84.04Mycosis fungoides, lymph nodes of axilla and upper limb
C84.05Mycosis fungoides, lymph nodes of inguinal region and lower limb
C84.06Mycosis fungoides, intrapelvic lymph nodes
C84.07Mycosis fungoides, spleen
C84.08Mycosis fungoides, lymph nodes of multiple sites
C84.09Mycosis fungoides, extranodal and solid organ sites
C84.0AMycosis fungoides, in remission
C84.60Anaplastic large cell lymphoma, ALK-positive, unspecified site
C84.61Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck
C84.62Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes
C84.63Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes
C84.64Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb
C84.65Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb
C84.66Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes
C84.67Anaplastic large cell lymphoma, ALK-positive, spleen
C84.68Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites
C84.69Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites
C84.6AAnaplastic large cell lymphoma, ALK-positive, in remission
C84.90Mature T/NK-cell lymphomas, unspecified, unspecified site
C84.91Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck
C84.92Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes
C84.93Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes
C84.94Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb
C84.95Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb
C84.96Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes
C84.97Mature T/NK-cell lymphomas, unspecified, spleen
C84.98Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites
C84.99Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites
C84.9AMature T/NK-cell lymphomas, unspecified, in remission
C84.A0Cutaneous T-cell lymphoma, unspecified, unspecified site
C84.A1Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck
C84.A2Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes
C84.A3Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes
C84.A4Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb
C84.A5Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb
C84.A6Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes
C84.A7Cutaneous T-cell lymphoma, unspecified, spleen
C84.A8Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites
C84.A9Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites
C84.AACutaneous T-cell lymphoma, unspecified, in remission
C84.Z0Other mature T/NK-cell lymphomas, unspecified site
C84.Z1Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck
C84.Z2Other mature T/NK-cell lymphomas, intrathoracic lymph nodes
C84.Z3Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes
C84.Z4Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb
C84.Z5Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb
C84.Z6Other mature T/NK-cell lymphomas, intrapelvic lymph nodes
C84.Z7Other mature T/NK-cell lymphomas, spleen
C84.Z8Other mature T/NK-cell lymphomas, lymph nodes of multiple sites
C84.Z9Other mature T/NK-cell lymphomas, extranodal and solid organ sites
C84.ZAOther mature T/NK-cell lymphomas, in remission
C86.00Extranodal NK/T-cell lymphoma, nasal type not having achieved remission
C86.01Extranodal NK/T-cell lymphoma, nasal type, in remission
C86.10Hepatosplenic T-cell lymphoma not having achieved remission
C86.11Hepatosplenic T-cell lymphoma, in remission
C86.20Enteropathy-type (intestinal) T-cell lymphoma not having achieved remission
C86.21Enteropathy-type (intestinal) T-cell lymphoma, in remission
C86.60Primary cutaneous CD30-positive T-cell proliferations not having achieved remission
C86.61Primary cutaneous CD30-positive T-cell proliferations, in remission
C91.A0Mature B-cell leukemia Burkitt-type not having achieved remission
C91.A1Mature B-cell leukemia Burkitt-type, in remission
C91.A2Mature B-cell leukemia Burkitt-type, in relapse
C92.20Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
C92.21Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission
C92.22Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
C92.90Myeloid leukemia, unspecified, not having achieved remission
C92.91Myeloid leukemia, unspecified in remission
C92.92Myeloid leukemia, unspecified in relapse
C92.Z0Other myeloid leukemia not having achieved remission
C92.Z1Other myeloid leukemia, in remission
C92.Z2Other myeloid leukemia, in relapse
C93.10Chronic myelomonocytic leukemia not having achieved remission
C93.11Chronic myelomonocytic leukemia, in remission
C93.12Chronic myelomonocytic leukemia, in relapse
C93.30Juvenile myelomonocytic leukemia, not having achieved remission
C93.31Juvenile myelomonocytic leukemia, in remission
C93.32Juvenile myelomonocytic leukemia, in relapse
C93.90Monocytic leukemia, unspecified, not having achieved remission
C93.91Monocytic leukemia, unspecified in remission
C93.92Monocytic leukemia, unspecified in relapse
C93.Z0Other monocytic leukemia, not having achieved remission
C93.Z1Other monocytic leukemia, in remission
C93.Z2Other monocytic leukemia, in relapse
C94.30Mast cell leukemia not having achieved remission
C94.31Mast cell leukemia, in remission
C94.32Mast cell leukemia, in relapse
C94.80Other specified leukemias not having achieved remission
C94.81Other specified leukemias, in remission
C94.82Other specified leukemias, in relapse

What changed from V24

The payment year 2025 mapping carries both models for the same codes. Of the 238 codes it maps to V28 HCC 20, every one already paid under V24; the largest source is V24 HCC 10 (Lymphoma and Other Cancers) with 147 codes. The V28 community, non-dual, aged factor is 1.136 against 0.675 for V24 HCC 10.

V24 categories that the HCC 20 codes belonged to (PY2025 mapping)
V24 HCCV24 categoryCodes now in HCC 20V24 codes with no V28 HCCV24 factor (CNA)
10Lymphoma and Other Cancers1470 of 5950.675
9Lung and Other Severe Cancers900 of 1101.024
11Colorectal, Bladder, and Other Cancers10 of 1330.307

V24 and V28 number their categories independently, so the same diagnosis usually carries a different HCC number in each model. The V24 to V28 crosswalk report lists every category pair, and the glossary explains the 2020 CMS-HCC V24 model and the V28 model that replaced it.

Inpatient groups where these diagnoses land

Appendix B of the v44 MS-DRG Definitions Manual places the codes in this category in the logic of 40 MS-DRGs. The groups with the most shared codes are below; a hospital stay coded with one of these diagnoses groups there when it is the principal diagnosis, or when the DRG's logic uses it as a qualifying secondary diagnosis.

MS-DRGs whose logic lists the most HCC 20 codes
MS-DRGTitleShared codes
DRG 820Lymphoma and Leukemia with Major O.R. Procedures with MCC139
DRG 821Lymphoma and Leukemia with Major O.R. Procedures with CC139
DRG 822Lymphoma and Leukemia with Major O.R. Procedures without CC/MCC139
DRG 823Lymphoma and Non-Acute Leukemia with Other Procedures with MCC139
DRG 824Lymphoma and Non-Acute Leukemia with Other Procedures with CC139
DRG 825Lymphoma and Non-Acute Leukemia with Other Procedures without CC/MCC139
DRG 840Lymphoma and Non-Acute Leukemia with MCC139
DRG 841Lymphoma and Non-Acute Leukemia with CC139
DRG 842Lymphoma and Non-Acute Leukemia without CC/MCC139
DRG 974HIV with Major Related Condition with MCC86

Local coverage policies that list these diagnoses

Medicare Administrative Contractors name covered ICD-10-CM codes in the billing and coding articles attached to their LCDs. These policies share the most codes with HCC 20 in the current Medicare Coverage Database export (one policy per topic; overlap counts after each). For the services these policies govern, the same diagnoses are covered indications, so the documentation that supports the category also supports the claim for the service.

Where these codes sat in the V22 model

The V28 recalibration renumbered and regrouped categories; this table shows which legacy V22 categories the same ICD-10 codes belonged to, which is the quickest way to reconcile a V22-era HCC gap list with the current model.

V22 categories that the HCC 20 codes mapped to
V22 HCCCodes
10142
990
111

Part D: the RxHCC categories of these codes

The same diagnoses feed the RxHCC model, which adjusts Medicare Part D payments. Of the 233 codes in HCC 20, 228 also map to a prescription drug category and 5 carry none; the categories are below, and the RxHCC hub has their 2027 MA-PD, PDP and PACE factors.

RxHCC V08 categories that the HCC 20 codes map to
RxHCCCategoryCodes
RxHCC 21Lymphomas and Other Hematologic Cancers86
RxHCC 22Prostate, Breast, Bladder, and Other Cancers and Tumors54
RxHCC 19Leukemias and Other Hematologic Cancers52
RxHCC 20Lung, Kidney, and Other Cancers; Secondary Cancer of Lymph Nodes and Other Sites36

Capturing and defending the category

A category counts for a payment year when a mapped diagnosis is documented at least once during the data collection year by an acceptable provider type at a face-to-face or audio-video encounter, and when the note shows the condition was monitored, evaluated, assessed or treated. Chronic conditions do not carry forward: a category that is not re-documented in the year drops out of the score, which is why annual wellness visits and problem-list reconciliation are where most recapture happens. Risk adjustment data validation audits sample enrollees and ask for the medical record behind each submitted category; an unsupported category is removed and, under the extrapolation rules, the error rate is applied across the contract. The QuickIntell risk adjustment product surfaces suspected and unsupported categories from the chart, and the HCC hub lists every V28 category with its factor and code count.

For teams evaluating QuickIntell software

Evaluate risk adjustment review software

For teams reviewing documentation across a cohort, explore source evidence, proposed findings, reviewer decisions and audit handoffs. Confirm the program, payment year and model scope during evaluation. A category lookup is not a patient-specific coding or payment determination.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

Which ICD-10 codes map to HCC 20?

233 ICD-10-CM codes map to HCC 20 in the CMS PY2027 initial mapping, for example C15.3 Malignant neoplasm of upper third of esophagus; C15.4 Malignant neoplasm of middle third of esophagus; C15.5 Malignant neoplasm of lower third of esophagus; C15.8 Malignant neoplasm of overlapping sites of esophagus. The full list is on this page; a code counts only when it is documented at a face-to-face or video encounter in the data collection year and supported by the record.

How much does HCC 20 add to a risk score?

The V28 relative factor for HCC 20 is 1.136 for a community, non-dual, aged beneficiary, 1.166 for full-benefit dual aged, 0.978 for non-dual disabled and 0.672 for long-term institutional members. A factor of 1.000 equals the expected annual cost of an average beneficiary, so the category's share of the payment follows the plan's base rate for that segment.

Does HCC 20 count together with related categories?

No. Within a hierarchy only the most severe category is paid. HCC 20 is dropped when HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) or HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid) or HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers) is also present, and it drops HCC 21, HCC 22, HCC 23 when it is present.

What has to be documented for HCC 20 to be valid?

One of the 233 mapped codes (such as C15.3) must be recorded by an acceptable provider type during a face-to-face or audio-video encounter in the service year, with the note showing that the condition (Lung and Other Severe Cancers) was monitored, evaluated, assessed or treated. Risk adjustment data validation audits recover payment for categories the record does not support, so the code on the claim and the assessment in the note must match.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

Relative factors and mappings are reproduced from the CMS risk adjustment model files as an operational reference. Payment depends on the plan's base rate, normalization, the coding intensity adjustment and the enrollee's segment. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.